Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,312 | -11,681 | -6,093 | -20,010 | 0 |
| Depreciation Amortization | 944 | 581 | 276 | 920 | 0 |
| Other Working Capital | -447 | -406 | -638 | 1,840 | 0 |
| Other Operating Activity | 792 | 261 | 110 | -60 | 0 |
| Operating Cash Flow | $-17,023 | $-11,245 | $-6,345 | $-17,310 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,747 | -5,397 | -5,397 | N/A | 0 |
| PPE Investments | -249 | -249 | -211 | -640 | 0 |
| Investing Cash Flow | $-4,996 | $-5,646 | $-5,608 | $-640 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | 5,000 | N/A | N/A | 0 |
| Common Stock Issued | 72 | 70 | 13 | N/A | 0 |
| Other Financing Activity | -775 | 0 | 0 | 50,730 | 0 |
| Financing Cash Flow | $4,297 | $5,070 | $13 | $50,730 | $0 |
| Beginning Cash Position | 36,457 | 36,457 | 36,457 | 3,670 | 0 |
| End Cash Position | 18,735 | 24,636 | 24,517 | 36,450 | 0 |
| Net Cash Flow | $-17,722 | $-11,821 | $-11,940 | $32,780 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,023 | -11,245 | -6,345 | -17,310 | 0 |
| Capital Expenditure | -249 | -249 | -211 | N/A | 0 |
| Free Cash Flow | -17,272 | -11,494 | -6,556 | -17,310 | 0 |